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Bisphenol A (BPA) is an estrogenic compound 
that was originally synthesized in the 1930s for 
pharmaceutical purposes (Dodds 1936). In the 
1960s, the U.S. Food and Drug Administration 
approved alternative applications of BPA for 
use in hard polycarbonate plastics and, eventu-
ally, a wide variety of other consumer products, 
including dental sealants, food can linings, and 
water bottles (Food and Drug Administration 
2010). Recent studies document that > 90% of 
the general population has measurable concen-
trations of urinary BPA, reflecting widespread 
exposure (Vandenberg et al. 2010). Although 
BPA has been identified in many commercial 
and industrial products, potential sources of 
BPA exposure in the general population still 
remain to be determined.
Because BPA is estrogenic, it has the 
potential to affect hormone-mediated neuro-
logic and behavioral development in early life 
and is recognized as an endocrine-disrupting 
chemical. In 2008, a National Toxicology 
Program (NTP) expert panel identified BPA 
as having the potential to affect the develop-
ing fetal brain based on a number of animal 
studies reporting abnormalities in offspring 
after in utero exposures (Chapin et al. 2008).
The Health Outcomes and Measures of the 
Environment Study (HOME Study) is a pro-
spective birth cohort study in Cincinnati, Ohio, 
that was designed to examine sources and expo-
sures to a variety of prenatal and postnatal envi-
ronmental toxicant exposures, including BPA, 
and subsequent health and neuro  behavioral 
outcomes in children (Dietrich et al. 2005). 
The study obtained prenatal spot urine samples 
at approximately 16 and 26 weeks gestation 
and within 24 hr of delivery for assessment 
of maternal phthalate (chemicals used in plas-
tics and personal care products) and BPA con-
centrations [Centers for Disease Control and 
Prevention (CDC) 2010]. Whole-blood and 
serum samples, collected from the mother at 
the same time points, were also analyzed for 
lead and cotinine, a metabolite of nicotine and 
biomarker of tobacco smoke exposure (CDC 
2010). All laboratory analyses were performed 
by the National Center for Environmental 
Health at the CDC in Atlanta, Georgia (CDC 
2010). Questionnaires on demographic and 
lifestyle characteristics were administered at 
approximately 20 weeks gestation, at birth, 
and at yearly childhood assessments from 
1 to 5 years of age. Neurobehavioral assess-
ments of infants and children were performed 
at birth, at 1 month of age, and then annually 
from 1 to 5 years using a full battery of vali-
dated   psychometric tests.
This case study focuses on a mother in the 
HOME Study who had the highest reported 
BPA concentration in the cohort. Her male 
infant had a normal newborn examination fol-
lowed by abnormal neurobehavioral findings 
on the Neonatal Intensive Care Unit Network 
Neurobehavioral Scale (NNNS) at 27 days of 
age. The NNNS is a comprehensive neuro-
behavioral assessment that assesses neurologic 
functioning, provides a behavioral profile, and 
measures signs of stress/abstinence in healthy 
and at-risk newborns. Summary scales allow 
for quantification along 13 dimensions of 
neuro  logic status and behavior. The stress/
abstinence scale can be broken down into 
seven smaller subscales that describe specific 
organ systems (Lester and Tronick 2004).
Ethical considerations. The institutional 
review boards (IRBs) of the University of 
North Carolina–Chapel Hill, Cincinnati 
Children’s Hospital and Medical Center, the 
University of Washington, and the CDC 
approved this case study. The University of 
Cincinnati College of Medicine IRB was 
involved in the oversight of this study in the 
early stages of planning and implementa-
tion. All mothers provided written informed 
consent for themselves and their children 
before enrollment in the HOME Study. The 
mother of this case infant has also provided 
consent specific to the publication of this case 
report. The HOME Study reported the pre-
natal BPA and phthalate results to all partici-
pants for whom there was sufficient sample 
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Co n t e x t: Most of the U.S. population is exposed to the high-production-volume chemical 
  bisphenol A (BPA), but targetable sources of exposure remain to be determined. Animal studies and 
one human study suggest that BPA is a neurotoxicant.
Ca s e p r e s e n t a t i o n: A mother in the Health Outcomes and Measures of the Environment 
(HOME) Study, a prospective birth cohort examining prenatal and postnatal environmental toxi-
cants and childhood health outcomes, had a urinary BPA concentration of 583 µg/g creatinine at 
27 weeks of pregnancy, which was the highest concentration observed in this cohort (median, 
2.0 µg/g creatinine) and the general population. We used prenatal questionnaire data and a 
follow-up interview to identify potential sources of exposure that included daily plastic use and con-
sumption of canned beverages and foods. Her male infant had a normal newborn neurobehavioral 
assessment but presented with abnormalities at the 1-month examination that prompted physician 
referral. Subsequently, the child had normal neurobehavioral testing results at annual evaluations 
from 1 to 5 years of age.
DisCussion: Investigations into sources of high gestational urinary BPA concentrations provide an 
opportunity to identify potential targets for reduction of BPA exposure. This case highlights a poten-
tial link between gestational BPA exposure and transient neurobehavioral changes that is hypothesis 
generating and can serve to alert researchers to potential areas for examination in future studies.
relevanCe t o C l i n i C a l p r a C t i C e: It is important to educate health care practitioners regarding 
potential sources of BPA exposure and anticipatory guidance on minimization of exposures during 
vulnerable periods of development.
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volume to conduct testing, and the handout 
from the Pediatric Environmental Health 
Specialty Unit (PEHSU) website [Association 
of Occupational and Environmental Clinics 
(AOEC) 2009] was also mailed to study 
participants. The case infant’s mother was 
individually counseled regarding her elevated 
prenatal BPA concentration and how to mini-
mize BPA exposures.
Case Presentation
The case mother was a 26-year-old African-
American woman (case mother) with three 
reported past pregnancies and one living child; 
she had no significant past medical history 
and negative prenatal laboratory testing for 
hepatitis B, syphilis, group B streptococcus, 
and glucose intolerance. She had a 27-week 
urinary BPA concentration of 583 µg/g crea-
tinine (1,250 µg/L). This was the highest BPA 
value recorded within the entire cohort (n = 
389 participants and 1,100 urine samples) 
(Table 1). Her other prenatal urinary BPA 
concentrations at 16 weeks and a birth were 
at the 84th (4.1 µg/g) and 49th (1.9 µg/g) 
percentiles, respectively. Because of concerns 
that the 583 µg/g urinary BPA concentra-
tion could be a spurious finding, we followed 
up with the CDC National Environmental 
Health Laboratory. The CDC confirmed this 
result by reextracting the sample twice to con-
duct repeat testing. The values obtained were 
very close to the value originally reported and 
higher than the highest standard on the cali-
bration curve. They also documented that 
most BPA in the urine was conjugated and 
therefore did not reflect external contami-
nation. The case mother had concentrations 
of serum cotinine, blood lead, and urinary 
phthalates ranging from the 25th to 84th per-
centiles within the cohort (Table 1).
The mother of our case infant is an 
African-American woman with > 12 years of 
education. She was unemployed throughout 
the pregnancy and living with her 4-year-old 
daughter during the time she was pregnant 
with the case infant. The Home Observation 
for the Measurement of the Environment 
inventory (HOME inventory) scale (Caldwell 
and Bradley 2003) score at the child’s first 
birthday was 31, which suggested a low qual-
ity and quantity of stimulation and support 
available in the home environment (Table 2).
The case male infant was born in 2004, at 
term (39 weeks of gestation) by spontaneous 
vaginal delivery without complications. Labor 
and delivery were unremarkable, with Apgar 
scores of 9/9 at 1 and 5 min of age. The infant 
had a normal course in the newborn nurs-
ery and a normal NNNS at 14 hr and was 
discharged from the hospital approximately 
38 hr after birth.
At the 1-month neurobehavioral assess-
ment, completed on the 27th day of life during 
a home visit, the infant displayed the following 
clinical signs or symptoms: hypertonicity in 
the trunk and upper and lower extremities, 
setting sun sign, tremors, cogwheel movements 
and athetoid finger posturing, high-pitch cry, 
and extreme irritability (Table 3). Compared 
with other infants in the HOME Study, this 
infant had high NNNS scores for excitabil-
ity, lethargy, and stress abstinence (reflecting 
a higher level of the neurobehavioral dimen-
sion) and lower scores for regulation and qual-
ity of movement (Table 4). Within the stress 
abstinence subscales, autonomic stress, cen-
tral nervous system stress, and state stress were 
elevated compared with the rest of the cohort. 
Two dimensions of the NNNS—attention 
and handling—could not be assessed because 
the extreme irritability of the infant prevented 
completion of key items. In addition, habitu-
ation could not be assessed because it requires 
the subject to be asleep, which is uncommon at 
the 1-month examination because most infants 
are awake and interactive; approximately 89% 
of infants in the HOME Study cohort could 
not be assessed for habituation for this reason. 
The neurologic signs and behaviors noted on 
the individual exam for the case infant were 
clearly abnormal. The infant was referred to 
his primary care physician for follow-up and 
further workup, if indicated. All other general 
physical examination findings were reported 
as normal in the infant’s medical records. The 
infant went on to have annual neurobehavioral 
assessments at 1–5 years of age that were within 
normal limits. All neurologic assessments were 
performed by trained examiners within the 
HOME Study who were blinded to prenatal 
biomonitoring results.
To determine potential sources of the ele-
vated urinary BPA concentration and to follow 
up on the development of the child, we used 
the prenatal questionnaire (completed in 2004) 
and conducted a focused follow-up telephone 
interview with the mother in the fall of 2009. 
We developed interview questions based on 
the mother’s responses to prenatal question-
naires collected at 22 weeks gestation, with the 
goal of potentially identifying specific sources 
of BPA exposure in the fall of 2004 when the 
26-week urine sample was collected. From 
the 2004 questionnaire, we learned that the 
mother was single and unemployed. Although 
she reported being a nonsmoker with no expo-
sure to second-hand smoke during pregnancy, 
her serum cotinine values in fact indicated 
exposure to second-hand tobacco smoke. Her 
values were not high enough for her to be clas-
sified as a smoker and were consistent across 
the pregnancy. The mother did report occa-
sionally drinking wine between the estimated 
date of conception and 15 weeks gestation, 
but the amount never exceeded one drink in a 
typical day. She reported no illicit drug use and 
took no medications or supplements during her 
pregnancy except for prenatal vitamins during 
the first trimester. She reported drinking five 
canned soda beverages per week in the month 
before completing her prenatal questionnaire at 
22 weeks gestation. These beverages included a 
combination of Pepsi (excluding Pepsi One), 
Coca-Cola (excluding Diet Coke), Ruby Red, 
Storm, Big Red, Snapple flavored teas, and 
KMX. Her diet consisted of canned or frozen 
vegetables one to three times per week and 
fresh vegetables four to six times per week. Her 
diet also included fish, meat, and dairy and was 
generally high in fat, including approximately 
four fast-food meals per week.
At the 2009 follow-up interview, the 
mother reported eating canned ravioli (generic 
Table 1. Prenatal concentrations of urinary BPA, phthalate, and serum cotinine for the case infant’s mother compared with values in the full HOME Study cohort.
16 Weeks 26 Weeks Birth
Metabolite
Median 
(25th, 75th percentile)
Case 
value
Case 
percentile
Median 
(25th, 75th percentile)
Case 
value
Case 
percentile
Median 
(25th, 75th percentile)
Case 
value
Case 
percentile
BPA (µg/g creatinine) 1.7 (1.1, 3.0) 4.1 83.7 2.0 (1.3, 3.2) 583.0 100 2.0 (1.2, 3.0) 1.9 48.8
LMW phthalates (µM/g)a 11.8 (6.4, 26.1) 13.5 55.2 11.7 (6.0, 28.5) 19.5 65.7 11.2 (5.9, 22.7) 19.5 70.3
HMW phthalates (µM/g)b 3.6 (2.1, 6.7) 4.4 60.9 3.3 (2.1, 7.2) 2.1 27.3 10.5 (4.4, 22.4) 4.4 24.8
DEHP metabolites (µM/g)c 2.5 (1.4, 5.3) 3.6 63.5 2.4 (1.4, 5.1) 1.6 30.5 9.1 (3.2, 21.7) 4.3 31.2
DBP metabolites (µM/g)d 1.4 (0.9, 2.1) 1.8 67.4 1.4 (0.9, 2.3) 1.3 42.4 1.3 (0.7, 2.5) 0.7 24.5
Cotinine (ng/mL) 0.03 (< LOD, 0.2) 0.07 60.5 0.03 (< LOD, 0.2) 0.1 67.1 0.02 (< LOD, 0.2) 0.1 70.5
Lead (µg/dL) 0.7 (0.5, 0.9) 0.8 64 0.7 (0.5, 0.9) 0.6 43 0.8 (0.6, 1.0) 0.6 32
LOD, limit of detection. All phthalates are creatinine standardized.
aLow-molecular-weight (LMW) phthalates were monobutyl phthalate, monoethyl phthalate, and monoisobutyl phthalate. bHigh-molecular-weight (HMW) phthalates were monobenzyl 
phthalate, mono(2-ethylhexyl) phthalate, mono(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-oxohexyl) phthalate, and mono-(3-
carboxypropyl) phthalate. cDi(2-ethylhexyl) phthalate (DEHP) metabolites were mono(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-
oxohexyl) phthalate, and mono(2-ethylhexyl) phthalate. dDibutyl phthalate (DBP) metabolites were monobutyl phthalate and monoisobutyl phthalate.Sathyanarayana et al.
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brand) every day during the period in which 
the 26-week urine sample was taken. Her 
daily exposure to plastics included heating 
and use of plastic food storage containers in 
the microwave and eating and drinking from 
plastic plates and cups. She used a municipal 
water supply and did not know what kind 
of plumbing was used in her home. She did 
not report being hospitalized or receiving 
any kind of inpatient medical care during 
her pregnancy. Except for a tooth extraction 
before 16 weeks of gestation, she had no other 
dental work performed for the duration of the 
pregnancy. She was unemployed throughout 
the pregnancy and living with her 4-year-old 
daughter during the time she was pregnant 
with the case infant. Her home was within 
2 miles of a whiskey factory, but there were 
no other industrial buildings in close proxim-
ity. Regarding her child’s medical condition, 
she stated that her primary care physician fol-
lowed her child with normal checkups and 
did not note any abnormal behavioral or 
developmental findings or other health prob-
lems. The mother reported the child was in 
school and performing well.
Discussion
We report on a mother who had a pre  natal 
urinary BPA concentration two orders of 
magnitude higher than the mean or median 
urinary BPA levels documented in previous 
biomonitoring studies. We identified mul-
tiple potential sources of BPA exposure that 
could be avoided during vulnerable periods of 
development, including canned beverages and 
foods. Her infant had normal neurobehavior 
at birth followed by abnormal arousal, regula-
tion, quality of movement, excitability, and 
lethargy at 1 month of age. The temporal rela-
tionship of the extremely high prenatal BPA 
value with the transient abnormal neurobe-
havioral findings is hypothesis generating and 
raises the question about whether these find-
ings reflect BPA toxicity. However, the abnor-
mal neurobehavior at 1 month might have 
been a result of another etiology, given that 
the infant had normal findings at birth and 
from 1 to 5 years of age. This case highlights a 
potential association between gestational BPA 
exposure and transient neurodevelopmental 
findings that can alert researchers to potential 
areas for examination in future investigations 
and epidemiologic studies.
The mother’s BPA concentration at 
27 weeks of pregnancy was higher than any 
reported in the peer-reviewed literature for 
a person in the general population (CDC 
2010; Vandenberg et al. 2010). Consumption 
of contaminated food and beverages is 
thought to be the single largest contributor 
to BPA exposure in the general population 
(Vandenberg et al. 2010; von Goetz 2010). 
Recent data show that airborne BPA may also 
be an important source of exposure (Fu and 
Kawamura 2010). The case mother reported 
eating canned ravioli daily during her sec-
ond and third trimesters of pregnancy and 
eating canned or frozen vegetables one to 
three times per week in her prenatal ques-
tionnaire. Food can linings may contain BPA 
that can leach into foods (Vandenberg et al. 
2007). The degree of BPA leaching increases 
under acidic, basic, and high-temperature 
Table 3. Clinically significant results of NNNS exam for the case infant at 1 month of age.
Abnormal findings in case NNNS exam Neurobehavioral symptoms
Displayed hypertonicity in trunk, neck, and 
upper/lower extremities
Excessive or above-normal muscle tone or tension; the infant’s 
musculature becomes “stiff” or rigid, and the infant shows 
marked resistance to passive movements.
Setting sun sign observed during first third 
of examination
Eyes point downward, pupils partially covered by lower eyelids, 
and sclera visible above the pupils.
Low-frequency/high-amplitude tremors and 
high-frequency/low-amplitude tremors
Tremors are rapid, rhythmic oscillation movements with a 
segmented quality.
Cogwheel movements Movements are slower, coglike, jerky. 
Athetoid posture of fingers observed at 
beginning of examination
Some of the fingers are fully flexed while others are 
simultaneously extended, simultaneous flexion of the elbow 
and rotation of the upper limb, or extension at the elbow with 
rotation of the wrist. Athetoid movements are slow, writhing 
changes from one athetoid posture to another.
High-pitch cry Infant’s cry is high pitched at any time during the examination 
when the infant is in a sustained crying state.
Extreme irritability Infant fusses or cries throughout the examination. The fuss/cry 
seems to be insulated in the sense that is seems to control 
the infant and determines the flow of the exam. This is the 
infant who is “at the mercy” of his or her fussiness. Crying is 
persistent and excessive. The infant cries to minimal as well as 
vigorous handling and maybe even without stimulation.
Table 2. Demographic characteristics of the case mother–infant pair compared with the full cohort (n = 389).
Variable
Full cohort: women  
and children [n (%)] Case mother
Child sex
Female 208 (53.5)
Male 181 (46.5) X
Missing 0
Maternal race
White 237 (61.7)
Nonwhite 147 (38.3) X
Missing 5
Maternal education (years)
< 12 41 (10.7)
12 54 (13.8)
> 12 289 (74.5) X
Missing 5
Income category (US$ per year)
< 40,000 153 (40.7) X
40,000 to < 80,000 120 (31.9)
≥ 80,000 103 (27.4)
Missing 13
Marital status
Married 249 (64.8)
Single 135 (35.2) X
Missing 5
Maternal age category (years)
< 25 96 (24.7)
25–34 231 (59.4) X
≥ 35 62 (15.9)
Missing 0
HOME score category (12 months)
< 35 51 (15.3) X
35–39 64 (19.2)
≥ 40 219 (65.6)
Missing 55
Beck Depression Inventory at 20 weeks
Minimal or mild depression (0–19) 345 (92.0) X
Moderate or severe depression (≥ 20) 30 (8.0)
Missing 14High prenatal bisphenol A exposure and infant neurobehavior
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conditions. Canned beverages are also docu-
mented sources of BPA exposure (Cao et al. 
2009). The case mother reported drinking 
five canned beverages per week in the month 
before the 22-week questionnaire. This overall 
consumption pattern could have contributed 
to her high exposure concentration. A recent 
study showed that replacing canned and 
packaged foods with fresh foods in one’s diet 
significantly lowered urinary BPA concentra-
tions (Rudel et al. 2011). Consistently using 
and microwaving plastics (including plastic 
plates, cups, and food storage containers used 
to store and reheat foods) may have also led 
to the increased urinary BPA concentration. 
Hard polycarbonate plastic, cardboard food 
storage containers, and plastic stretch film can 
contain BPA (Vandenberg et al. 2007).
Although we were unable to identify 
a specific exposure that led to the isolated 
high BPA concentration early in the third 
trimester, the combination of reported expo-
sures may have contributed to the higher 
BPA concentration. BPA concentrations can 
vary considerably during the day based on 
multiple exposures and within person based 
on individual metabolism. Mahalingaiah 
et al. (2008) found that single urine samples 
showed moderate sensitivity for predicting 
a pregnant woman’s exposure categoriza-
tion over time, but it is possible that the case 
mother’s prenatal BPA concentration was a 
transient value that does not reflect exposures 
throughout the second and third trimesters of 
pregnancy. It is also possible that an unidenti-
fied source of BPA was the primary source of 
the elevated prenatal exposure concentration. 
Finally, recall bias may have affected answers 
to follow-up questions regarding prenatal 
exposures because the follow-up interview 
occurred 5 years after the infant was born. 
In 2004, we acquired data from the 22-week 
questionnaire on canned beverage consump-
tion that asked about exposures in the month 
before completing the questionnaire. We did 
not have specific prenatal questionnaire data 
at the exact time when the 26-week urine 
sample was collected but did review responses 
from the 22-week questionnaire with the 
mother and confirmed reported lifestyle and 
dietary responses for the 26-week period.
Demographic factors can also be associ-
ated with overall exposure concentrations, and 
women from low socioeconomic backgrounds 
tend to have slightly higher urinary BPA con-
centrations than do women from higher socio-
economic strata (Braun et al. 2010). Although 
she was unemployed and had a low HOME 
inventory score, her demographic profile did 
not stand out in any particular manner from 
the rest of the enrolled women (Table 2).
Data on prenatal BPA exposures and 
potential health impacts in humans are lim-
ited. An earlier study from this cohort showed 
a positive association between prenatal urinary 
BPA concentrations at 16 weeks of pregnancy 
and increased externalizing behavior, repre-
senting acting out styles that are categorized on 
hyperactivity and aggression scales, in female 
children at 2 years of age (Braun et al. 2009b). 
The mother of the male case infant had a BPA 
concentration that was much higher than 
the median of the cohort and was therefore 
excluded from that analysis. The abnormalities 
in the case infant’s neurologic outcomes and 
behaviors at the 1-month examination were 
not observed in the overall cohort analysis for 
BPA exposure (data not shown). Ten singleton 
infants in the cohort were referred to a physi-
cian for abnormal NNNS findings after the 
1-month examination. The geometric mean 
26-week prenatal BPA concentrations for the 
10 mothers of infants who were referred based 
on NNNS findings at the 1-month exami-
nation were higher than those for the moth-
ers of 345 infants who were not referred (5.8 
vs. 2.2 µg/g creatinine). The ratio of these 
values is 2.67 (95% confidence interval, 
1.62–4.40). However, these results should be 
interpreted cautiously given the small   number 
of referred infants.
Multiple animal studies cite neurologic 
abnormalities in offspring after in utero BPA 
exposures (Chapin et al. 2008; NTP 2008). 
In mice, high-dose (50 mg/kg) prenatal BPA 
exposures were associated with increased anxi-
ety in male offspring compared with females, 
and Cox et al. (2010) postulated that this could 
be attributable to impacts on the dopaminergic 
or estrogen receptor-β pathways. Kawai et al. 
(2003) found that prenatal low-dose (2 ng/g 
and 20 ng/g) BPA exposures were associated 
with a transient increased aggression score in 
male rats at 8 weeks of age that resolved at 
12 weeks and thereafter. This transient nature 
of the neurobehavioral changes is similar to 
that of our case infant, whose symptoms of 
increased hypertonicity, tremors, abnormal 
movements, and extreme irritability at 1 month 
of age resolved in later testing.
Other environmental chemicals and 
endocrine-disrupting compounds, such as 
phthalates, lead, mercury, polychlorinated 
biphenyls, and pesticides, can also play a 
role in neurodevelopment. In a multiethnic 
cohort study of newborns in New York City, 
third-trimester urinary concentrations of some 
phthalate metabolites were associated with 
decreased orientation and alertness scores in 
girls and improved motor performance in 
boys assessed with the Neonatal Behavioral 
Assessment Scale at 5 days of age (Engel et al. 
2009). These exposures were also associated 
with elevated scores on conduct and aggression 
problem scales in children at 4 and 9 years 
of age (Engel et al. 2010). The same urinary 
phthalate metabolites were measured in this 
case study mother (Table 1) and were within 
the interquartile ranges of those reported for 
the women in the New York City cohort. Few 
animal and human studies examine prenatal 
exposure to mixtures of chemicals and sub-
sequent neurodevelopmental health impacts. 
Therefore, it is difficult to know whether the 
mother’s exposures to other environmen-
tal chemicals may have played a role in the 
infant’s neurologic development.
The NNNS is a validated tool to assess 
neurobehavior during early infancy (Lester and 
Tronick 2004). It was originally designed to 
assess neurobehavioral effects of prenatal expo-
sure to drugs of abuse and prematurity, but it 
Table 4. Results of NNNS summary scores for the case infant at 1 month of age compared with mean 
values for the full cohort.
One-month NNNS value
Cohort
NNNS scale Case  n Mean ± SD
Attention NA 336 5.40 ± 1.38
Arousal 5 336 4.18 ± 0.69
Regulation 4.07 352 5.53 ± 0.79
Handling NA 348 0.45 ± 0.31
Quality of movement 3.83 355 4.81 ± 0.59
Excitability 8 335 2.44 ± 2.03
Lethargy 9 355 4.12 ± 1.76
Nonoptimal reflexes 2 355 3.97 ± 1.63
Asymmetry 1 355 1.23 ± 1.08
Hypertonia 0 355 0.04 ± 0.21
Hypotonia 0 355 0.28 ± 0.55
Stress abstinence totala 0.27 355 0.13 ± 0.05
Physiologic stress 0 355 0.03 ± 0.12
Autonomic stress 0.33 355 0.14 ± 0.15
CNS stress 0.5 355 0.17 ± 0.12
Skin stress 0 355 0.11 ± 0.11
Visual stress 0.23 335 0.15 ± 0.09
Gastrointestinal stress 2 355 1.97 ± 0.11
State stress 0.29 335 0.14 ± 0.11
Abbreviations: CNS, central nervous system; NA, not assessed.
aThe stress abstinence total reflects a summary of the seven subscales listed below.Sathyanarayana et al.
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can also be used to assess healthy and at-risk 
infants (Lester and Tronick 2004). The clini-
cal significance of an abnormal NNNS exam 
in the neonatal period for functioning in later 
childhood has yet to be determined, but Liu 
et al. (2010) reported the NNNS to be highly 
predictive of behavior problems, school readi-
ness, and intelligence through age 4.5 years in 
at-risk children. Additional studies are neces-
sary to validate the predictive ability of the 
NNNS in representative samples. Neonatal 
neurobehavior can be quite variable depending 
on timing of the examination as well as envi-
ronmental factors, but the 1-month assessment 
time has been used in many published studies 
and is a more stable time point for evaluat-
ing newborn neuro  behavior (Xu et al. 2011). 
Normal physical examinations of newborn 
infants by medical providers quickly assess 
neurologic status by examining reflexes, tone, 
and general behavior but do not sensitively 
assess the specific of neurologic and behavioral 
factors that are assessed by the NNNS. Other 
infants within the HOME Study had abnor-
mal neuro  logic examinations, but some of 
these mothers did not have elevated prenatal 
urinary BPA concentrations. These cases may 
have resulted from other etiologies of abnor-
mal neurobehavior that have not yet been 
explored. The case infant displayed abnormal 
neurologic signs and behaviors at the 1-month 
examination, with no obvious etiology, which 
prompted us to conduct this case study. It is 
unclear how long these symptoms were present 
after the NNNS assessment. These abnormal 
findings were not noted by any other medical 
assessments performed by health care provid-
ers, including the primary medical doctor for 
the infant.
Other potential causes of abnormal neuro-
behavioral findings in an infant include brain 
injury due to hypoxic injury at birth, genetic 
causes, or some kind of postbirth neurologic 
insult (Paine 1961; Volpe 2008). The birth 
record documented a normal labor and deliv-
ery without insult, and there was no known 
family history of abnormal neurologic disease. 
Signs and symptoms of these types of insults 
can present immediately or take several days 
to manifest. Neurologic deficits with known 
etiology tend to persist past the neonatal 
period and take considerable time to resolve, 
if they resolve at all. The case infant had an 
isolated abnormal neurobehavioral exami-
nation at 1 month of age but without any 
apparent sequelae. No significant medical his-
tory that could have contributed to neurologic 
disease is noted in the medical record, and the 
mother stated that her infant had a normal 
course after discharge from the hospital. We 
did not identify an alternative etiology for the 
abnormal neurobehavioral findings from the 
medical record/questionnaire from 2004 or 
maternal interview in 2009.
This case study highlights a high pre-
natal urinary BPA concentration at 26-week 
gestation and an abnormal neurobehavioral 
examination at 1 month of age. It is likely that 
multiple sources of BPA exposure, which may 
have been avoided with appropriate education 
and resources, contributed to the mother’s 
elevated urinary concentration during preg-
nancy. This case raises the intriguing possi-
bility that gestational BPA exposure may be 
associated with abnormal infant neurobehav-
ior, because BPA is a suspected neurotoxicant 
that has elicited transient abnormal findings 
in toxicologic studies. Case reports or series of 
high-dose BPA exposures during fetal develop-
ment offer a unique approach to study sources 
of BPA exposure and potential targets of toxic-
ity. It is reassuring that the infant’s neurologic 
status was normal at follow-up, but the long-
term health impacts of in utero BPA exposure 
remain to be determined by future studies that 
assess longitudinal developmental outcomes.
Relevance to Clinical Practice
The result of this case study confirms previ-
ous studies documenting multiple sources 
of BPA exposure in humans. These findings 
can alert and inform health care practitioners 
that the general population can be exposed 
to high concentrations of BPA during gesta-
tion, a critical time for organ system and brain 
develop  ment. There is increasing concern 
regarding gestational exposure to endocrine-
disrupting chemicals such as BPA because of 
evidence that environmental toxicants may be 
associated with an elevated risk for abnormal 
neurodevelopment (Braun et al. 2006, 2009a; 
Carpenter and Nevin 2009; Mendola et al. 
2002). These conditions present significant 
economic and psychosocial public health bur-
dens for our society.
In light of evidence supporting BPA and 
other environmental toxicants as potential 
human health hazards, health care provid-
ers should be prepared to learn about BPA 
and other environmental endocrine-disrupt-
ing chemicals and to appropriately coun-
sel patients on how to minimize exposures. 
Health care providers can learn how to con-
duct an appropriate environmental history 
and assessment and to consider potential 
health impacts through a variety of resources 
(listed in Table 5). They can also consult with 
physicians professionally trained in environ-
mental health to help address specific medical 
conditions that may be related to BPA and 
other endocrine-disrupting chemical expo-
sures through university-based PEHSUs that 
consist of physicians and other environmental 
Table 5. Evidence-based pediatric environmental health resources for health care practitioners.a
Organization/program Description Contact information Funding source
Association of Occupational and 
Environmental Clinics: Pediatric 
Environmental Health Specialty Units 
(PEHSUs) (2006)
Made up of professionally trained 
environmental health experts, 
including physicians; provide evidence-
based education and consultations to 
health care providers, state and local 
governments, and individual families
http://www.aoec.org/PEHSU.htm U.S. Environmental Protection Agency, Centers 
for Disease Control and Prevention, Agency 
for Toxic Substances and Disease Registry
American Academy of Pediatrics: 
Pediatric Environmental Health 
handbook (Green Book) (2003)
Provides description and clinical 
guidelines for addressing common 
pediatric environmental health topics
https://www.nfaap.org/netforum/
eweb/dynamicpage.aspx?site=nf.
aap.org&webcode=aapbks_
productdetail&key=17837ee5-f0fd-
4486-9bcc-64f986b0f703
American Academy of Pediatrics
National Environmental Education 
Foundation: Pediatric Environmental 
History Initiative (2011)
Provides numerous resources on 
environmental education, including 
handouts on taking a pediatric 
environmental health history
http://www.neefusa.org/health/PEHI/
index.htm 
Chartered by Congress in 1990 under the 
National Environmental Education Act to 
advance environmental knowledge and action
Physicians for Social Responsibility: 
Pediatric Environmental Health Toolkit 
(2009)
Provides evidence-based environmental 
health tool kits for health care 
providers to use; health care providers 
can earn CME credit for taking the 
tool-kit course
http://www.psr.org/resources/
pediatric-toolkit.html#what 
Physicians for Social Responsibility, a not-for-
profit 501(c)(3) advocacy organization that 
won the Nobel peace prize in 1985 and is 
funded by private individual donations as well 
as charitable group donations
CME, Continuing Medical Education.
aTable adapted from J.M. Braun and R. Hauser (2011), “Bisphenol A and children’s health” (Curr Opin Pediatr 23(2):233–239), with permission from Lippincott, Walters, and Wilkins.High prenatal bisphenol A exposure and infant neurobehavior
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public health professionals (AOEC 2006). The 
PEHSUs have created handouts for health 
care providers and patients on chemicals in 
plastics, potential harmful effects, and how to 
avoid exposures (AOEC 2009). Industry can 
also help educate health care practitioners and 
consumers by providing information on prod-
ucts containing BPA and reduce exposures in 
manufacturing when possible.
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